KB

Kenneth Buckfire

North America, New York, United States, New York

Description

Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.

Investor Profile

Kenneth Buckfire has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kenneth Buckfire frequently co-invest with?

6V
Europe, Hainaut, Belgium, Charleroi
Co-Investments: 1
Smedvig
Europe, Rogaland, Norway, Stavanger
Co-Investments: 1
Meusinvest (Noshaq)
Europe, Liege, Belgium, Liège
Co-Investments: 1
Sambrinvest
Europe, Hainaut, Belgium, Gosselies
Co-Investments: 1
Co-Investments: 1
Mérieux Equity Partners
Europe, Rhone-Alpes, France, Lyon
Co-Investments: 1

What are some of recent deals done by Kenneth Buckfire?

Amyl Therapeutics

Liège, Liege, Belgium

Amyl Therapeutics is a preclinical stage biotechnology company.

BiotechnologyHealth CareLife ScienceMedical
Series AJun 3, 2021
Amount Raised: $10,432,525